Regeneron is a biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions.
Marketed Products
Regeneron has received marketing approval from the U.S. Food and Drug Administration (FDA) for ARCALYST® (rilonacept) Injection for Subcutaneous Use for a rare inflammatory condition.
Advanced Product Candidates
In clinical trials for a wide range of solid tumors.
In clinical trials for wet Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME).
In clinical trials for the prevention of gout flares in patients initiating urate-lowering therapy and in the treatment of acute gout flares.
Three human antibodies developed under the sanofi-aventis collaboration are in clinical development.
Named one of Best Places to Work
Regeneron.jobs
Clinical Trials
